Table 1.
Experimental Group | Sham – Control Group | Group Comparisons | |
---|---|---|---|
Number of Participants | 18 | 17 | – |
Sex | 12 Females | 13 Females | χ2 = 0.412; p = 0.52; φ = 0.11 |
Age | 40.28 ± 12.21 | 45.88 ± 12.63 | t(33) = -1.33; p = 0.19; dz = 0.225 |
CAPS – Total | 36.86 ± 10.36 | 39.64 ± 7.97 | t(33) = -0.90; p = 0.37; dz = 0.152 |
CTQ – Total | 54.61 ± 19.88 | 62.50 ± 19.73 | t(33) = -1.16; p = 0.25; dz = 0.196 |
MDI – Total | 52.89 ± 14.87 | 67.75 ± 21.46 | t(33) = -2.36; p = 0.02; dz = 0.398 |
MDD | Current/Past = 5/8 | Current/Past = 6/5 | χ2 = 0.23/0.85; p = 0.63/0.36; φ = 0.08/−0.15 |
Somatization Disorder | Current/Past = 1/0 | Current/Past = 3/0 | χ2 = 1.26/–; p = 0.26/–; φ = 0.19/– |
Specific Phobia | Current/Past = 0/0 | Current/Past = 1/0 | χ2 = 1.09/– ; p = 0.30/–; φ = 0.18/– |
Medication | 12 | 11 | χ2 = 0.015; p = 0.90; φ = -0.02 |